Business
Extension of territories for Seed Health's DS-01
Extension of territories for Seed Health's DS-01.

About this update from Optibiotix Health Plc
[{"type":"text","content":"\n \n \n \n RNS Number : 0619I\n OptiBiotix Health PLC\n 10 August 2021\n \n \n \n OptiBiotix Health plc\n (\"OptiBiotix\" or the \"Company\" or the \"Group\")\n \n Extension of territories for Seed Health's DS-01 product\n \n \n OptiBiotix Health plc (AIM: OPTI), a life sciences business developing compounds to tackle obesity, high cholesterol, diabetes and skincare,announces that its wholly-owned subsidiary, ProBiotix Health Ltd, has extended the territories of its original agreement (RNS: 22 May 2018) with Seed Health, Inc. ('SeedTM') for the production, promotion, marketing and commercialisation of products containing LPLDL®. The agreement extends the territories from the USA, to include the countries within Europe, Oceania (e.g. Australia, New Zealand etc), and Asia (excluding India) for the supply of LPLDL® in SeedTM's DS-01 product, a multi-strain synbiotic product which contains OptiBiotix's Lactobacillus plantarum LPLDL®. DS-O1 received FDA authorisation for an Investigational New Drug (\"IND\") in October 2020 (RNS: 2 October 2020) for IBS applications. \n \n \n Seed\n TM\n \n (\n seed.com\n ) \n was co-\n founded by Raja Dhir and Ara Katz \n to pioneer the development of \n next-generation probiotic and live biotherapeutic applications and recently closed a $40m Series A funding round to fund new category launches and international expansion. \n This agreement supports the SeedTMexpansion plans for DS-01 and is another example of OptiBiotix's partners either extending their product range (e.g. Optipharm, Holland and Barrett) or, as in this case, taking existing products into new territories. This extension will contribute to growing the Group's recurring revenue and demonstrates the effectiveness of the Company's strategy of diversifying routes to market through multiple partnership agreements.\n \n \n \n \n Stephen O'Hara, CEO of OptiBiotix, commented:\n \n \"We are pleased to strengthen our already strong relationship with Seed Health by agreeing this territory expansion for DS-01 to support their ambitious growth plans. This is another example of OptiBiotix's partners extending their product range or expanding existing products into new territories.\n \n This helps to grow the existing re...